Loading...
Back to narrative

HNST: Transformation 2.0 Will Drive Recovery Despite Lowered Guidance

Update shared on 24 Nov 2025

Fair value Decreased 28%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-59.4%
7D
-3.6%

Analysts have reduced their price target for Honest Company, lowering it from $4.25 to $3 per share. They cite weaker than anticipated third-quarter performance and ongoing uncertainty in the company's outlook.

Analyst Commentary

Following the latest price target adjustment, analysts have noted a combination of positive factors and ongoing concerns impacting Honest Company's valuation and outlook.

Bullish Takeaways

  • Bullish analysts point to the company's ongoing transformation initiatives. These efforts, they suggest, could drive operational improvements over time.
  • The maintenance of an Equal Weight rating by some experts reflects a belief that downside risk may be partially offset by potential stability as initiatives unfold.
  • Some see the lowered expectations setting a more attainable benchmark for Honest, which could be favorable if execution improves in coming quarters.

Bearish Takeaways

  • Bearish analysts highlight the weaker than expected third quarter and lower full-year guidance as major headwinds weighing on the company's fundamental outlook.
  • Visibility remains low for Honest, with uncertainty around the timing and impact of its Transformation 2.0 strategy posing challenges for both growth and valuation.
  • Concerns persist around the company’s ability to restore investor confidence and achieve sustainable revenue growth in a competitive market environment.

What's in the News

  • Honest Company has lowered its full fiscal year 2025 revenue guidance and now expects revenue to be between $367 million and $378 million, reflecting a range of negative 3% to flat growth. (Key Developments)
  • The adjusted outlook comes amid potential risks from winding down strategic exits as well as ongoing declines in diaper revenue, particularly anticipated in the fourth quarter. (Key Developments)
  • Organic revenue growth for the year is projected to be 4% to 6%, with organic revenue expected between $292 million and $298 million. (Key Developments)
  • The company cites uncertainty in the macroeconomic environment as a contributing factor to its more cautious guidance. (Key Developments)

Valuation Changes

  • The Fair Value Estimate has decreased significantly from $5.29 per share to $3.83 per share.
  • The Discount Rate has declined slightly from 7.58% to 7.47%.
  • The Revenue Growth Projection has shifted from an expected increase of 2.14% to a projected decrease of 3.17%.
  • The Net Profit Margin Estimate has improved, rising from 2.86% to 3.60%.
  • The Future Price-to-Earnings (P/E) Ratio has declined considerably from 76.7x to 45.6x.

Have other thoughts on Honest Company?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.